Is local review of positron emission tomography scans sufficient in diffuse large B‐cell lymphoma clinical trials? A CALGB 50303 analysis is a research paper published in Cancer Medicine (2023). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: UG1CA189960
National Institutes of Health
Grant: UG1CA233339
National Institutes of Health
Grant: UG1CA233331
National Institutes of Health
Grant: UG1CA233290
National Institutes of Health
Grant: UG1CA233191
National Institutes of Health
Grant: U10CA180882
National Institutes of Health
Grant: U10CA180821
Wyeth
Grant: HHSN261200800001E
NCI NIH HHS
Grant: U10 CA180833
NCI NIH HHS
Grant: R01 CA240759
NCI NIH HHS
Grant: P30 CA008748
NCI NIH HHS
Grant: U10 CA180791
NCI NIH HHS
Grant: U10 CA180888
National Institutes of Health
Grant: 3UG1CA233191-06S1
Network Lead Academic Participating Site Grant from the Roswell Park Cancer Institute
National Institutes of Health
Grant: 3UG1CA233339-06S1
Washington University/Siteman Cancer Center Lead Academic Site
National Institutes of Health
Grant: 5UG1CA233331-03
OSU as a Network Lead Academic Participating Site for the NCI NCTN
National Institutes of Health
Grant: 5UG1CA189960-02
Columbia University Minority/Underserved Site NCI Community Oncology Research Program
National Institutes of Health
Grant: 3U10CA180821-02S2
Alliance for Clinical Trials in Oncology Operations Center
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
National Institutes of Health
Grant: 3UG1CA233290-06S1
Lead Academic Participating Site: Memorial Sloan Kettering Cancer Center
National Institutes of Health
Grant: 5U10CA180882-02
Statistics and Data Center for the Alliance for Clinical Trials in Oncology
Leukemia and Lymphoma Society
GlaxoSmithKline
Johnson and Johnson
AstraZeneca
Pfizer
Amgen
Merck
FWCI
0.89
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals